Evaluation of P38 MAPK pathway as a molecular signature in ulcerative colitis

Journal of Proteome Research

Volumn 10, Issue 5, 2011, Pages 2216-2225

  Zhao, Xinmei ^a   Kang, Bin ^b,c   Lu, Chaolan ^a   Liu, Siqi ^b   Wang, Huanjing ^a   Yang, Xiaoming ^a   Chen, Ye ^a   Jiang, Bo ^a   Zhang, Jun ^b,c   Lu, Youyong ^b,c   Zhi, Fachao ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

MAWBP; molecular signature; P38 MAPK pathway; proteomics; ulcerative colitis

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIN; BIOLOGICAL MARKER; GALECTIN 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN MAWBP; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENZYME PHOSPHORYLATION; EVALUATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; UPREGULATION; VALIDATION PROCESS; WESTERN BLOTTING;

BIOLOGICAL MARKERS; BLOTTING, WESTERN; COLITIS, ULCERATIVE; GALECTIN 3; GENE EXPRESSION REGULATION; HUMANS; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEINS; PROTEOMICS; PYRIDINES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 79955876589     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100969w     Document Type: Article

References (33)

1. Katz, J. The course of inflammatory bowel disease Med. Clin. North Am. 1994, 78, 1275-80 (Pubitemid 24359169)
2. Prantera, C. When is it time for surgery in severe ulcerative colitis? Inflamm. Bowel Dis. 2008, 14 (Suppl 2) S240
3. Rutter, M. D.; Saunders, B. P.; Wilkinson, K. H. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk Gut 2004, 53, 1813-6 (Pubitemid 39556902)
4. Allison, J.; Herrinton, L. J.; Liu, L. Natural history of severe ulcerative colitis in a community-based health plan Clin. Gastroenterol. Hepatol. 2008, 6, 999-1003
5. Nikolaus, S.; Schreiber, S. Diagnostics of inflammatory bowel disease Gastroenterology 2007, 133, 1670-89 (Pubitemid 350029755)
6. Jiang, L.; Xia, B.; Li, J. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China Inflamm. Bowel Dis. 2006, 12, 212-7
7. Jiang, X. L.; Cui, H. F. An analysis of 10218 ulcerative colitis cases in China World J. Gastroenterol. 2002, 8, 158-61
8. Wang, Y.; Ouyang, Q. Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients J. Gastroenterol. Hepatol. 2007, 22, 1450-5 (Pubitemid 47274580)
9. Rudmik, L. R.; Magliocco, A. M. Molecular mechanisms of hepatic metastasis in colorectal cancer J. Surg. Oncol. 2005, 92, 347-59 (Pubitemid 41779295)
10. Hsieh, S. Y.; Shih, T. C.; Yeh, C. Y. Comparative proteomic studies on the pathogenesis of human ulcerative colitis Proteomics 2006, 6, 5322-31
11. Shkoda, A.; Werner, T.; Daniel, H. Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease J. Proteome Res. 2007, 6, 1114-25 (Pubitemid 46480475)
12. Schroeder, K. W.; Tremaine, W. J.; Ilstrup, D. M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study N. Engl. J. Med. 1987, 317, 1625-9 (Pubitemid 18010466)
13. Zarubin, T.; Han, J. Activation and signaling of the p38 MAP kinase pathway Cell Res. 2005, 15, 11-8 (Pubitemid 41653958)
14. Cheng, T. J.; Tseng, Y. F.; Chang, W. M. Retaining of the assembly capability of vimentin phosphorylated by mitogen-activated protein kinase-activated protein kinase-2 J. Cell Biochem. 2003, 89, 589-602
15. Zhang, Y; Zhou, Z. H.; Bugge, T. H. Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin J. Immunol. 2007, 179, 3297-304
16. Bellmann, K.; Burkart, V.; Bruckhoff, J. p38-dependent enhancement of cytokine-induced nitric-oxide synthase gene expression by heat shock protein 70 J. Biol. Chem. 2000, 275, 18172-9 (Pubitemid 30414768)
17. Huang, C. K.; Zhan, L.; Ai, Y. LSP1 is the major substrate for mitogen-activated protein kinase-activated protein kinase 2 in human neutrophils J. Biol. Chem. 1997, 272, 17-9 (Pubitemid 27021115)
18. Urbanelli, L.; Emiliani, C.; Massini, C. Cathepsin D expression is decreased in Alzheimer's disease fibroblasts Neurobiol. Aging 2008, 29, 12-22 (Pubitemid 350102710)
19. Wang, X.; Khaleque, M. A.; Zhao, M. J. Phosphorylation of HSF1 by MAPK-activated protein kinase 2 on serine 121, inhibits transcriptional activity and promotes HSP90 binding J. Biol. Chem. 2006, 281, 782-91
20. Fernandez, G. C.; Ilarregui, J. M.; Rubel, C. J. Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways Glycobiology 2005, 15, 519-27 (Pubitemid 41214397)
21. Schwertz, H.; Carter, J. M.; Abdudureheman, M. Myocardial ischemia/reperfusion causes VDAC phosphorylation which is reduced by cardioprotection with a p38 MAP kinase inhibitor Proteomics 2007, 7, 4579-88
22. Herde, P.; Blankenfeldt, W. The purification, crystallization and preliminary structural characterization of human MAWDBP, a member of the phenazine biosynthesis-like protein family Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun. 2006, 62, 546-9 (Pubitemid 43892135)
23. Cho, J. H. The genetics and immunopathogenesis of inflammatory bowel disease Nat. Rev. Immunol. 2008, 8, 458-66 (Pubitemid 351733422)
24. Elson, C. O.; Cong, Y.; Weaver, C. T. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice Gastroenterology 2007, 132, 2359-70 (Pubitemid 46890867)
25. Duerr, R. H.; Taylor, K. D.; Brant, S. R. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene Science 2006, 314, 1461-3 (Pubitemid 44871953)
26. Andoh, A.; Shioya, M.; Nishida, A. Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease J. Immunol. 2009, 183, 687-95
27. Ueyama, H.; Kiyohara, T.; Sawada, N. High Fas ligand expression on lymphocytes in lesions of ulcerative colitis Gut 1998, 43, 48-55 (Pubitemid 28335489)
28. Maynard, C. L.; Weaver, C. T. Intestinal effector T cells in health and disease Immunity 2009, 31, 389-400
29. Hollenbach, E.; Neumann, M.; Vieth, M. Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease FASEB J. 2004, 18, 1550-2 (Pubitemid 39561629)
30. Waetzig, G. H.; Seegert, D.; Rosenstiel, P. p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease J. Immunol. 2002, 168, 5342-51 (Pubitemid 34496003)
31. Iriyama, C.; Matsuda, S.; Katsumata, R. Cloning and sequencing of a novel human gene which encodes a putative hydroxylase J. Hum. Genet. 2001, 46, 289-92 (Pubitemid 32410682)
32. Celis, J. E.; Gromova, I.; Gromov, P. Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia FEBS Lett. 2006, 580, 2935-44 (Pubitemid 43729167)
33. Varambally, S.; Yu, J.; Laxman, B. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression Cancer Cell 2005, 8, 393-406 (Pubitemid 41579834)